New clinical application of high-intensity focused ultrasound: Local control of synovial sarcoma

13Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

High-intensity focused ultrasound (HIFU) is playing an increasingly important role in cancer therapy. Primary synovial sarcomas of the chest wall are extremely rare. We report the first case of noninvasive HIFU therapy for the control of synovial sarcoma. A 51-year-old man was diagnosed with spindle cell sarcoma on the left chest wall through lumpectomy. After four cycles of chemotherapy, local recurrence of the sarcoma was detected. Subsequent extended resection confirmed synovial sarcoma. After five cycles of a new chemotherapy option, the sarcoma relapsed again. Then the patient received five courses of HIFU; this completely ablated the sarcoma without complications. No chemotherapy, radiotherapy, or biological therapy has been applied since. Now the patient is stable and has a high quality of life. © 2013 Hu et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Hu, X., Cai, H., Zhou, M., He, H., Tian, W., Hu, Y., … Deng, Y. (2013). New clinical application of high-intensity focused ultrasound: Local control of synovial sarcoma. World Journal of Surgical Oncology, 11. https://doi.org/10.1186/1477-7819-11-265

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free